Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: An update of data from a randomised, double-blind, phase 3 trial

Jared M. Baeten, Deborah Donnell, Nelly R. Mugo, Patrick Ndase, Katherine K. Thomas, James D. Campbell, Jonathan Wangisi, Jordan W. Tappero, Elizabeth A. Bukusi, Craig R. Cohen, Elly Katabira, Allan Ronald, Elioda Tumwesigye, Edwin Were, Kenneth H. Fife, James Kiarie, Carey Farquhar, Grace John-Stewart, Lara Kidoguchi, Robert W. CoombsCraig Hendrix, Mark A. Marzinke, Lisa Frenkel, Jessica E. Haberer, David Bangsberg, Connie Celum

Research output: Contribution to journal › Article › peer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: An update of data from a randomised, double-blind, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences